Live Quote · NASDAQGRCEHealthcare· Biotechnology

Grace Therapeutics, Inc.

$1.71▼ 1.16%($-0.02)
MKT CAP $27.83MNEXT EARNINGS Feb 15, 2027
50%
Bullish
TickerSpark Score
56/100
▌ Mixed
87
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRCE research report →

Analyst Price Target
$4.00+133.9% vs. today

Range $4 – $4

Analyst RatingBuy
2 Buy0 Hold0 Sell

Price Chart

-45.54% · this period
$5.13$3.42$1.71Nov 20May 26Nov 20
52-Week Range2% of range
Low
$1.64
Current
$1.71
High
$5.18